Laroprovstat not checked

AstraZeneca · AZD0780 · Dose 1

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
6 active
20 in total · 5 in the EU
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“daily oral dose of the Placebo to match Laroprovstat and Laroprovstat/Rosuvastatin 1”In the company’s words, NCT07619131 on ClinicalTrials.gov
Tested for
Cardiovascular Disease (2 trials), Heterozygous Familial Hypercholesterolaemia, Hypercholesterolaemia, Hypercholesterolemia, Dyslipidaemia
Main trialPhase 3
“This is a study to evaluate the efficacy and safety of AZD0780 in adults with HeFH and elevated LDL-C, either with clinical ASCVD and LDL-C levels of 55 mg/dL or higher or without clinical ASCVD and LDL-C levels of 70 mg/dL or higher. AZD0780 is a small molecule that reduces the amount of LDL-C in the blood. Placebo will be used for comparison, and neither the participants nor the Investigators will know who is receiving the AZD0780 medication and who is receiving the placebo until the end of study. The total length of the study for an individual participant will be up to approximately 56…”In the company’s words, NCT07000136 on ClinicalTrials.gov
Other names
AZD0780 · Dose 1

Other drugs for Cardiovascular Disease

All 536 drugs for Cardiovascular Disease

Coming up6

Changes2

Last 90 days

Trials20

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting 4 Jan 2027 A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
Phase 3Active, not recruiting 11 Jan 2027 A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event
Phase 3Recruiting 30 Jul 2027 A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
Phase 3Not yet recruiting 11 Oct 2027 A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin, and Placebo on LDL-C in LLT-naïve Patients
Phase 3Recruiting 26 Oct 2029 A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Phase 2/3Active, not recruiting 22 Feb 2027 A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia
Phase 2Completed 30 Sep 2024 A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipidemia
Phase 2Completed 18 Apr 2025 A Study to Assess the Effect of AZD0780 on Ambulatory Blood Pressure
Phase 2Completed 3 Sep 2026 A Study to Investigate the Effect of AZD0780 Tablets in Combination With Rosuvastatin Tablets on Low Density Lipoprotein Cholesterol Levels (LDL-C) in Adult Participants With Dyslipidaemia
Phase 1Completed 15 May 2023 A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of Rosuvastatin.
Phase 1Completed 6 Jun 2023 An ADME Study of [14C]AZD0780 in Healthy Male Subjects
Phase 1Completed 14 Jun 2024 A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD0780 in Healthy Subjects
Phase 1Completed 8 Nov 2024 Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD0780
Phase 1Completed 1 Dec 2024 A Phase I Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD0780
Phase 1Completed 17 Feb 2025 An Open-label Study in Healthy Participants to Evaluate AZD0780 as an Object or Precipitant of CYP3A4-mediated Drug-drug Interactions
Phase 1Completed 29 Oct 2025 A Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Efficacy of AZD0780 With Ezetimibe Combinations in Healthy Adults With Elevated LDL-C.
Phase 1Completed 30 Dec 2025 A Study to Investigate the Effect of AZD0780 on Metformin Pharmacokinetics in Healthy Adult Volunteers Aged 18 to 55 Years
Phase 1Completed 5 Jun 2026 A Phase I Study Comparing the Relative Bioavailability of a Fixed-Dose Combination of Laroprovstat/Rosuvastatin vs Their Single Therapy Products in Healthy Adults
Phase 1Completed 29 Jun 2026 A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics With AZD0780 Following Repeated Dose Administration in Healthy Adults With Elevated LDL-C Levels
Phase 1Completed 8 Jul 2026 A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of AZD4954 and Vice Versa in Healthy Adults
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Laroprovstat

Following is part of Solo: you see every change to Laroprovstat the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in